Description

Next-generation psychedelic therapeutics for mental healthMindstate Design Labs develops psychedelic drug therapies for intractable mental health conditions. Our unique insights into the biological basis of the varieties of psychedelic experience enable the precision design of countless therapeutic mental states, beginning with our lead products: a 2nd generation MDMA and a 2nd generation psilocybin.

 


ACTIVE FOUNDERS

Founder 1

Dillan DiNardo,

Developing next-generation psychedelic therapeutics as Founder/CEO at Mindstate Design Labs. Biotech VC turned entrepreneur.

Twitter: https://twitter.com/DillanDiNardo | Linkedin: https://www.linkedin.com/in/dillandinardo/


Founder 2

Tom Ray,

BS in biology & chemistry Florida State University. MS & PhD in biology Harvard, tropical plant ecology. 1981 Society of Fellows U Michigan Ann Arbor. 1981-1998 faculty University Delaware, biology & computer science. 1993-2003 External Faculty of the Santa Fe Institute. 1993-1998 invited researcher ATR (Advanced Telecommunications Research Institute) Human Information Processing Research Labs in Japan. In 1998-present Professor of Biology & Computer Science OU. AAAS Fellow. http://tomray.me/

Twitter: | Linkedin: https://www.linkedin.com/in/tom-ray-a44a59204/


Founder 3

,

Twitter: | Linkedin:


Founder 4

,

Twitter: | Linkedin:


Founder 5

,

Twitter: | Linkedin:


Founder 6

,

Twitter: | Linkedin:

Based in

Pittsburgh

Nation
Founded in

2021

Team Size

2

Not Available
Today's work schedule is not available
  • Monday

    By appointment only

  • Tuesday

    N/A

  • Wednesday

    N/A

  • Thursday

    N/A

  • Friday

    N/A

  • Saturday

    N/A

  • Sunday

    N/A

  • 10 December 2022 6:16 local time

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected